AT
RMD icon

Avalon Trust’s ResMed RMD Stock Holding History

Avalon Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.3M Buy
95,017
+2,553
+3% +$636K 1.47% 20
2025
Q4 		$22.3M Buy
92,464
+834
+0.9% +$213K 1.44% 17
2025
Q3 		$25.1M Sell
91,630
-578
-0.6% -$158K 1.63% 16
2025
Q2 		$23.8M Sell
92,208
-3,577
-4% -$853K 1.74% 14
2025
Q1 		$21.4M Buy
95,785
+1,685
+2% +$393K 1.71% 17
2024
Q4 		$21.5M Sell
94,100
-465
-0.5% -$112K 1.53% 18
2024
Q3 		$23.1M Sell
94,565
-475
-0.5% -$106K 1.71% 20
2024
Q2 		$18.2M Buy
95,040
+350
+0.4% +$71K 1.44% 23
2024
Q1 		$18.8M Buy
+94,690
New +$17.4M 1.54% 23

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Avalon Trust's RMD Position: Q1 2026 in Review

Avalon Trust increased its ResMed (RMD) stake by 2.8% in Q1 2026, buying an estimated $636K and bringing the position to 95,017 shares worth $21.3M. The position accounts for 1.47% of the portfolio, ranked #20.

Avalon Trust first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $25.1M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Avalon Trust held 95,017 shares of ResMed worth $21.3M as of Q1 2026.
  • Avalon Trust bought 2,553 ResMed shares in Q1 2026, an estimated $636K.
  • ResMed made up 1.47% of Avalon Trust's portfolio in Q1 2026, its #20 holding.
  • Avalon Trust first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
  • Avalon Trust's ResMed position peaked at $25.1M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.